| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2011-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2017-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101736487-B1 |
| titleOfInvention |
Novel immunoadjuvant compounds and uses thereof |
| abstract |
The present invention relates to a cyclic beta-glucan compound for use as an immunoadjuvant and a vaccine composition containing the same. The novel adjuvant compounds particularly represent a novel family of dendritic cell activating molecules. |
| priorityDate |
2010-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |